Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL494502 (AC-264613) |
---|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
PAR2/Proteinase-activated receptor 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5963] [GtoPdb: 348] [UniProtKB: P55085] | ||||||||
ChEMBL | Agonist activity at human PAR2 expressed in HEK293T cells assessed as effect on intracellular calcium mobilization by R-SAT assay | F | 5 | pEC50 | >10000 | nM | EC50 | J Med Chem (2008) 51: 5490-5493 [PMID:18720984] |
GtoPdb | - | - | 7.5 | pEC50 | 31.6 | nM | EC50 | J Med Chem (2008) 51: 5490-3 [PMID:18720984] |
ChEMBL | Agonist activity at human PAR2 expressed in HEK293T cells assessed as effect on intracellular calcium mobilization by R-SAT assay | F | 7.5 | pEC50 | 31.62 | nM | EC50 | J Med Chem (2008) 51: 5490-5493 [PMID:18720984] |
ChEMBL | Agonist activity at human PAR2 expressed in HEK293T cells assessed as effect on intracellular calcium mobilization by R-SAT assay | F | 7.5 | pEC50 | 31.62 | nM | EC50 | J Med Chem (2008) 51: 5490-5493 [PMID:18720984] |
ChEMBL | Agonist activity at human PAR2 expressed in HEK293T cells assessed as increase in intracellular calcium level by bioluminescence assay | F | 7.52 | pEC50 | 30 | nM | EC50 | J Med Chem (2013) 56: 7477-7497 [PMID:23895492] |
ChEMBL | Agonist activity at human PAR2 expressed in HEK293T cells assessed as stimulation of phosphatidylinositol hydrolysis after 45 mins by scintillation counting analysis | F | 7.52 | pEC50 | 30 | nM | EC50 | J Med Chem (2013) 56: 7477-7497 [PMID:23895492] |
ChEMBL | Agonist activity at human PAR2 expressed in HEK293T cells assessed as stimulation of cell proliferation after 5 days by beta-galactosidase assay | B | 7.52 | pEC50 | 30 | nM | EC50 | J Med Chem (2013) 56: 7477-7497 [PMID:23895492] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]